Pinnacle Associates’s Twist Bioscience TWST Stock Holding History

Pinnacle Associates’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$302K	Buy	+1,562	New	+$193K	﹤0.01%	800

Other funds holding TWST

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Pinnacle Associates's TWST Position: Q3 2026 in Review

Pinnacle Associates opened a new position in Twist Bioscience (TWST) in Q3 2026: 1,562 shares worth $302K. The stake represents ﹤0.01% of the portfolio and ranks #800 among its holdings.

166 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

Pinnacle Associates held 1,562 shares of Twist Bioscience worth $302K as of Q3 2026.
Twist Bioscience was a new Pinnacle Associates position in Q3 2026.
Twist Bioscience made up ﹤0.01% of Pinnacle Associates's portfolio in Q3 2026, its #800 holding.
166 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on Pinnacle Associates's 13F filing for Q3 2026, filed 20 Oct 2026.